SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?


To: Tony van Werkhooven who wrote (416)1/12/1999 4:41:00 PM
From: DinoRia  Read Replies (2) | Respond to of 1386
 
Can anybody help me out on this problem.
PARS is (was) almost unknown in Belgium.
I'm posting on a local thread in Belgium about PARS, and try to share some info I find here and elsewhere, by translating it into our language (Flemish = Dutch).
Last days I got some very nasty postings from someone who alleges that PARS is nearly bankrupt, by stating that they have very big short-term (one year) debts, which they will not be able to repay.
I pointed to the 'burn rate' of Pars, the recent lending of $10 mio, and the expected earnings of Alrex, Lotemax and soon LE-T.
Can anybody tell me how much they will have to repay in 1 (one) year and if so, how they will repay it.

Thanks,

DinoRia